Related Experiment Videos
Norepinephrine therapy of ischemic optic neuropathy
Journal of Clinical Neuro-Ophthalmology
|December 1, 1981
Summary
Norepinephrine infusion to induce controlled hypertension may benefit selected patients with ischemic optic neuropathy and retinal ischemia unresponsive to steroids. Prompt treatment is crucial for visual recovery.
Area of Science:
- Ophthalmology
- Neurology
- Vascular Medicine
Background:
- Nonarteritic ischemic optic neuropathy (NAION) and retinal ischemia are vision-threatening conditions.
- Steroid therapy is a common treatment but can be ineffective in some cases.
Observation:
- Two patients with NAION and retinal ischemia unresponsive to steroids showed rapid visual improvement with intravenous norepinephrine-induced hypertension.
- A third patient experienced vision recovery in one eye with early NAION but not in an established lesion; later recurrences responded to hypertensive therapy.
Findings:
- Controlled hypertensive therapy using norepinephrine infusion can restore visual acuity in selected patients with recurrent NAION.
- Delayed treatment or established lesions may limit the efficacy of this intervention, as seen in a case requiring enucleation.
Implications:
- Norepinephrine-induced hypertension presents a potential therapeutic option for normotensive patients with NAION and retinal ischemia.
- Early intervention is critical for successful visual outcomes, highlighting the time-sensitive nature of ischemic optic neuropathies.